HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Frank Dicker Selected Research
Frank Dicker Research Topics
Disease
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2012 - 03/2005
4
Neoplasms (Cancer)
01/2018 - 09/2009
3
Chromosome Aberrations (Chromosome Abnormalities)
10/2010 - 11/2006
2
Leukemia
11/2006 - 09/2005
1
Blast Crisis (Blast Phase)
12/2019
1
Residual Neoplasm
11/2018
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2010
1
Philadelphia Chromosome
10/2010
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2009
Drug/Important Bio-Agent (IBA)
1
Dasatinib (BMS 354825)
FDA Link
12/2019
1
Tyrosine Kinase Inhibitors
IBA
12/2019
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
Transcription Factors (Transcription Factor)
IBA
02/2016
1
CD8 Antigens
IBA
05/2012
1
Phosphotransferases (Kinase)
IBA
10/2010
1
Imatinib Mesylate (Gleevec)
FDA Link
10/2010
1
Biological Products
IBA
10/2010
1
Nucleophosmin
IBA
09/2009
1
Oligonucleotides
IBA
11/2006
1
Interleukin-2 (IL2)
IBA
11/2006
1
CPG-oligonucleotide
IBA
11/2006
1
IgA receptor (protein B)
IBA
09/2005
1
CD40 Ligand (CD40L)
IBA
09/2005
1
Fas Ligand Protein (Fas Ligand)
IBA
04/2005
1
Immunoglobulin M (IgM)
IBA
03/2005
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
03/2005
Therapy/Procedure
2
Time-to-Treatment
10/2010 - 09/2010
1
Induction Chemotherapy
11/2018
1
Intravenous Infusions
11/2006
1
Drug Therapy (Chemotherapy)
11/2006
1
Ligation
04/2005